AstraZeneca makes donation to support bushfire crisis across Australia

Friday 10 January 2020 (SYDNEY): AstraZeneca today announced a $100,000 donation to support the State Fire Services and WIRES* across Australia to aid recovery efforts and recognised the extraordinary work of our volunteers and fire fighters across the country.

“There are horrific tales of lost homes, lost livelihoods and most tragically, the loss of loved ones. The impact on wildlife has also been dramatic. Fire fighters and wildlife rescue volunteers are doing an outstanding job and we want to do all we can to help them and provide relief to the community.” Pascal Soriot, Executive Director and Global CEO, AstraZeneca said.

Country President Australia & New Zealand, Liz Chatwin noted that many Australian employees have reached out wanting to help and understand how they individually and collectively as an organisation could contribute. “I have heard the call for action from our employees as they wish to ensure their colleagues are safe and at the same time deal with the impact more broadly in their own communities.” Ms Chatwin commented. AstraZeneca is committed to taking care of our employees and their loved ones, as well as supporting our impacted communities, patients, their homes and businesses, and our wildlife - both now and in the future. We have made the provision for employees to participate in several community service activities, including volunteering at the State Fire Services and State Emergency Services. We are committed to ensuring access to medicines for patients and continuity of supply.

AstraZeneca and Sustainability

AstraZeneca’s sustainability strategy is built around three pillars that put health at the heart of our work, Access to Health, Environmental Protection, and Ethics & Transparency. As a global company, we seek to leverage our reach, scale and expertise to effect real change in sustainability issues. Our employees work on initiatives ranging from preventative health screening in regions with unmet medical needs to workforce wellbeing. AstraZeneca has been named a sustainability leader in the Pharmaceuticals industry World Dow Jones Sustainability Index (DJSI World). The DJSI is the longest-running, global sustainability benchmark system and is based on an in-depth analysis of companies’ economic, social and environmental performance.

“As a sustainable organisation, our commitment to society, people and the planet lies at the heart of all that we do. I am tremendously proud of the progress that we continue to make; in particular, in our three priority areas: Access to Health, Environmental Protection, and Ethics & Transparency. As we enter a period of growth, sustainability will continue to play a key part in our success as a company. Central to this will be continued engagement with our stakeholders to ensure AstraZeneca remains valued and trusted as a source of great medicines and an indispensable ally in the quest to meet global healthcare challenges.” said Mr Soriot.

About AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas - Oncology, Cardiovascular, Renal and Metabolism (CVRM) and Respiratory. AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

*WIRES: Wildlife Information, Rescue and Education Service – Australia’s largest wildlife rescue organisation.

AstraZeneca Pty. Ltd. ABN 54 009 682 311. 66 Talavera Road, Macquarie Park, NSW 2113. AstraZeneca Medical Information: 1800 805 342. www.astrazeneca.com.au.

For more information, please visit www.astrazeneca.com and www.astrazeneca.com.au

 

-ENDS-


MEDIA CONTACT:

Cathy Sertori, Head of Patient Advocacy & Communication, AstraZeneca Australia

E: cathy.sertori@astrazeneca.com / M: 0429660335